肠道微生物组在炎症性肠病发病机制和治疗中的作用研究进展

doi:10.3969/j.issn.1674-8115.2022.03.015

上海交通大学学报（医学版） ›› 2022, Vol. 42 ›› Issue (3): 364-368.doi: 10.3969/j.issn.1674-8115.2022.03.015

肠道微生物组在炎症性肠病发病机制和治疗中的作用研究进展

李博文(), 刘宁宁(), 王慧()

上海交通大学公共卫生学院，上海 200025

收稿日期:2021-11-04 出版日期:2022-03-28 发布日期:2022-05-09
通讯作者: 刘宁宁,王慧 E-mail:maylee59@foxmail.com;liuningning@shsmu.edu.cn;huiwang@shsmu.edu.cn
作者简介:李博文（1996—），女，硕士生；电子信箱：maylee59@foxmail.com。
基金资助:
国家重点研发计划(2020YFA0907200);国家自然科学基金(81630086)

Advances in gut microbiota in the pathogenesis and treatment of inflammatory bowel disease

LI Bowen(), LIU Ningning(), WANG Hui()

Shanghai Jiao Tong University School of Public Health, Shanghai 200025, China

Received:2021-11-04 Online:2022-03-28 Published:2022-05-09
Contact: LIU Ningning,WANG Hui E-mail:maylee59@foxmail.com;liuningning@shsmu.edu.cn;huiwang@shsmu.edu.cn
Supported by:
National Key R&D Program of China(2020YFA0907200);National Natural Science Foundation of China(81630086)

摘要/Abstract

摘要：

肠道微生物组在人体健康中起着至关重要的作用。炎症性肠病（inflammatory bowel disease，IBD）是一种由多种环境因素（包括肠道微生物组）在遗传易感个体中引起的免疫疾病。尽管大多数研究表明肠道微生物组及其代谢物通过诱导炎症和免疫紊乱在肠道疾病的发生和发展中发挥作用，但仍无法确定微生物组与IBD发病机制之间的因果关系。该文总结了IBD发病过程中细菌、真菌和病毒微生物组的改变以及潜在的功能途径，探讨当前针对微生物组的治疗方法和前景。

关键词: 炎症性肠病, 生态失调, 微生物组, 真菌

Abstract:

The gut microbiota plays a critical role in human health. Inflammatory bowel disease (IBD) is an immunological disease caused by various environmental factors, including the gut microbiota, in genetically susceptible individuals. Although most studies have indicated the role of gut microbiota and their metabolites in contribution to the occurrence and development of intestinal diseases by inducing inflammation and immune disorders. However, the causal relationship between microbiota and IBD pathogenesis cannot be determined. In this review, the alteration of bacterial, fungal and viral microbiota and the potential functional pathways during IBD pathogenesis are summarized. Besides, the current therapeutic approaches targeting microbiota and the promising perspectives are introduced.

Key words: inflammatory bowel disease (IBD), dysbiosis, microbiota, fungus

中图分类号:

R574.4

李博文, 刘宁宁, 王慧. 肠道微生物组在炎症性肠病发病机制和治疗中的作用研究进展[J]. 上海交通大学学报（医学版）, 2022, 42(3): 364-368.

LI Bowen, LIU Ningning, WANG Hui. Advances in gut microbiota in the pathogenesis and treatment of inflammatory bowel disease[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(3): 364-368.

参考文献 40

1	GILBERT J A, BLASER M J, CAPORASO J G, et al. Current understanding of the human microbiome[J]. Nat Med, 2018, 24(4): 392-400.
2	NG S C, KAPLAN G G, TANG W, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific[J]. Am J Gastroenterol, 2019, 114(1): 107-115.
3	GUAN Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease[J]. J Immunol Res, 2019, 2019: 7247238.
4	PARK J, CHEON J H. Incidence and prevalence of inflammatory bowel disease across Asia[J]. Yonsei Med J, 2021, 62(2): 99-108.
5	LLOYD-PRICE J, ARZE C, ANANTHAKRISHNAN A N, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases[J]. Nature, 2019, 569(7758): 655-662.
6	HUGHES E R, WINTER M G, DUERKOP B A, et al. Microbial respiration and formate oxidation as metabolic signatures of inflammation-associated dysbiosis[J]. Cell Host Microbe, 2017, 21(2): 208-219.
7	KEITA ÅV, ALKAISSI L Y, HOLM E B, et al. Enhanced E. coli LF82 translocation through the follicle-associated epithelium in Crohn's disease is dependent on long polar fimbriae and CEACAM6 expression, and increases paracellular permeability[J]. J Crohns Colitis, 2019, 14(2): 216-229.
8	PALMELA C, CHEVARIN C, XU Z, et al. Adherent-invasive Escherichia coli in inflammatory bowel disease[J]. Gut, 2018, 67(3): 574-587.
9	ALAM M T, AMOS G C A, MURPHY A R J, et al. Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels[J]. Gut Pathog, 2020, 12: 1.
10	ISOBE J, MAEDA S, OBATA Y, et al. Commensal-bacteria-derived butyrate promotes the T-cell-independent IgA response in the colon[J]. Int Immunol, 2019, 32(4): 243-258.
11	GLASSNER K L, ABRAHAM B P, QUIGLEY E M M. The microbiome and inflammatory bowel disease[J]. J Allergy Clin Immunol, 2020, 145(1): 16-27.
12	LEYLABADLO H E, GHOTASLOU R, FEIZABADI M M, et al. The critical role of Faecalibacterium prausnitzii in human health: an overview[J]. Microb Pathog, 2020, 149: 104344.
13	ZHOU Y, XU H, XU J, et al. F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis[J]. AMB Express, 2021, 11(1): 33.
14	QUÉVRAIN E, MAUBERT MA, MICHON C, et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease[J]. Gut, 2016, 65(3): 415-425.
15	ELSON C O, CONG Y. Host-microbiota interactions in inflammatory bowel disease[J]. Gut Microbes, 2012, 3(4): 332-344.
16	VICH VILA A, IMHANN F, COLLIJ V, et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome[J]. Sci Transl Med, 2018, 10(472): eaap8914.
17	LUO W, SHEN Z, DENG M, et al. Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response[J]. Mol Med Rep, 2019, 20(2): 1007-1016.
18	HENKE M T, KENNY D J, CASSILLY C D, et al. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide[J]. PNAS, 2019, 116(26): 12672-12677.
19	DAI Z, ZHANG J, WU Q, et al. The role of microbiota in the development of colorectal cancer[J]. Int J Cancer, 2019, 145(8): 2032-2041.
20	BLANDFORD L E, JOHNSTON E L, SANDERSON J D, et al. Promoter orientation of the immunomodulatory Bacteroides fragilis capsular polysaccharide A (PSA) is off in individuals with inflammatory bowel disease (IBD)[J]. Gut Microbes, 2019, 10(5): 569-577.
21	LOPEZ-SILES M, ENRICH-CAPÓ N, ALDEGUER X, et al. Alterations in the abundance and co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects[J]. Front Cell Infect Microbiol, 2018, 8: 281.
22	ZHANG T, JI X, LU G, et al. The potential of Akkermansia muciniphila in inflammatory bowel disease[J]. Appl Microbiol Biotechnol, 2021, 105(14/15): 5785-5794.
23	SOKOL H, LEDUCQ V, ASCHARD H, et al. Fungal microbiota dysbiosis in IBD[J]. Gut, 2017, 66(6): 1039-1048.
24	LIMON J J, SKALSKI J H, UNDERHILL D M. Commensal fungi in health and disease[J]. Cell Host Microbe, 2017, 22(2): 156-165.
25	Bojang E, Ghuman H, Kumwenda P, et al. Immune sensing of Candida albicans[J]. J Fungi (Basel), 2021, 7(2): 1-16.
26	HOARAU G, MUKHERJEE PK, GOWER-ROUSSEAU C, et al. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn's disease[J]. mBio, 2016, 7(5): e01250-16.
27	TANG C, KAMIYA T, LIU Y, et al. Inhibition of dectin-1 signaling ameliorates colitis by inducing Lactobacillus-mediated regulatory T cell expansion in the intestine[J]. Cell Host Microbe, 2015, 18(2): 183-197.
28	LIGUORI G, LAMAS B, RICHARD M L, et al. Fungal dysbiosis in mucosa-associated microbiota of Crohn's disease patients[J]. J Crohns Colitis, 2015, 10(3): 296-305.
29	SIVIGNON A, DE VALLÉE A, BARNICH N, et al. Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn's disease[J]. Inflamm Bowel Dis, 2015, 21(2): 276-286.
30	CHIARO TR, SOTO R, ZAC STEPHENS W, et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice[J]. Sci Transl Med, 2017, 9(380): eaaf9044.
31	LIMON J J, TANG J, LI D, et al. Malassezia is associated with Crohn's disease and exacerbates colitis in mouse models[J]. Cell Host Microbe, 2019, 25(3): 377-388.e6.
32	TARRIS G, DE ROUGEMONT A, CHARKAOUI M, et al. Enteric viruses and inflammatory bowel disease[J]. Viruses, 2021, 13(1): 104.
33	GOGOKHIA L, BUHRKE K, BELL R, et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis[J]. Cell Host Microbe, 2019, 25(2): 285-299.e8.
34	LAM S, ZUO T, HO M, et al. Review article: fungal alterations in inflammatory bowel diseases[J]. Aliment Pharmacol Ther, 2019, 50(11/12): 1159-1171.
35	MILAJERDI A, EBRAHIMI-DARYANI N, DIELEMAN L A, et al. Association of dietary fiber, fruit, and vegetable consumption with risk of inflammatory bowel disease: a systematic review and meta-analysis[J]. Adv Nutr, 2020, 12(3): 735-743.
36	AKRAM W, GARUD N, JOSHI R. Role of inulin as prebiotics on inflammatory bowel disease[J]. Drug Discov Ther, 2019, 13(1): 1-8.
37	DIEDEREN K, LI J V, DONACHIE G E, et al. Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease[J]. Sci Rep, 2020, 10(1): 18879.
38	NICHOLSON M R, MITCHELL P D, ALEXANDER E, et al. Efficacy of fecal microbiota transplantation for Clostridium difficile infection in children[J]. Clin Gastroenterol Hepatol, 2020, 18(3): 612-619.e1.
39	BURRELLO C, GARAVAGLIA F, CRIBIÙ F M, et al. Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells[J]. Nat Commun, 2018, 9(1): 5184.
40	JAKUBCZYK D, LESZCZYŃSKA K, GÓRSKA S. The effectiveness of probiotics in the treatment of inflammatory bowel disease (IBD): a critical review[J]. Nutrients, 2020, 12(7): 1973.

[1]	梅一堃, 谭镜璁, 王安君, 王慧, 刘宁宁. 白念珠菌细胞壁结构及其与宿主相互作用的研究进展[J]. 上海交通大学学报(医学版), 2021, 41(9): 1246-1251.
[2]	李月1, 2，孙寒晓2，殳洁2，李咏梅1#，盛慧明2#. 利拉鲁肽作用肠道固有淋巴细胞改善小鼠炎症性肠病[J]. 上海交通大学学报(医学版), 2020, 40(6): 744-751.
[3]	周铖1，孙鹏飞2，尹继瑶3，王阳阳1，肖海娟4, 5. 粪菌移植治疗炎症性肠病的研究进展[J]. 上海交通大学学报（医学版）, 2020, 40(2): 267-.
[4]	秦蓉1, 2，何平1，张颐豪2，王砚春3. 肺部感染患者痰液与肺泡灌洗液病原菌分布及培养结果分析[J]. 上海交通大学学报(医学版), 2020, 40(12): 1621-1626.
[5]	韩阳 1, 2，朱丽红 3，骆菲 4，胡雯婧 4，秦金红 2，江滟 1. 高通量测序探究流产女性及未孕女性子宫内的菌群[J]. 上海交通大学学报（医学版）, 2019, 39(2): 165-.
[6]	赵乙汜1，余应喜1，林时辉2，徐昉1, 2. T细胞免疫在脓毒症继发侵袭性真菌感染中作用的研究进展[J]. 上海交通大学学报（医学版）, 2019, 39(11): 1325-.
[7]	白海涛, 王椿, 万理萍, 等. 卡泊芬净治疗异基因造血干细胞移植术后侵袭性真菌感染[J]. , 2013, 33(4): 468-.
[8]	陈峰, 陶晓勤, 刁文晶, 等. 国产血浆(1-3)-β-D葡聚糖检测试剂对侵袭性真菌病诊断价值评估[J]. , 2012, 32(3): 348-.
[9]	郑冰, 姚冬婷, 应春妹. 真菌基因分型方法研究进展[J]. , 2011, 31(10): 1475-.
[10]	张奕, 刘君, 赵纪余, 等. 65例慢性化脓性中耳炎伴真菌感染诊治分析[J]. , 2010, 30(10): 1254-.
[11]	王树云, 葛勤敏. 急诊ICU机械通气患者下呼吸道真菌感染临床分析[J]. , 2009, 29(8): 975-.

肠道微生物组在炎症性肠病发病机制和治疗中的作用研究进展

Advances in gut microbiota in the pathogenesis and treatment of inflammatory bowel disease

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 40

相关文章 11

编辑推荐

Metrics